30 November, 2020

‘India Will Need Hundreds Of Millions Of Doses’

Adar Poonawalla, CEO of Serum Institute, says he’s expecting the Indian trials of the Oxford vaccine to be over in January 2021.

‘India Will Need Hundreds Of Millions Of Doses’
outlookindia.com
2020-11-28T09:34:27+05:30

As the world’s largest vaccine manufacturer by volume of doses produced, the Pune-based Serum Institute of India is among the keenly-watched companies in the race for a COVID-19 vaccine. It is partnering with the Oxford University-AstraZeneca vaccine project, apart from two other candidates, in initial trials. Adar Poonawalla, CEO of Serum Institute, tells Ajay Sukumaran via email that he’s expecting the Indian trials of the Oxford vaccine to be over in January 2021. Edited excerpts:

How close is Oxford-Astra­Zeneca to delivering its COVID-19 vaccine under an emergency licence in the UK? How soon do you hope to get efficacy and safety data from your trials in India?

The UK trials are on the verge of completion, and our Indian trials are also going smoothly. Once the regulatory bodies are confident of its safety and efficacy, we can expect the vaccine to be available from January 2021.

ALSO READ:

unsub

THIS ARTICLE IS PRICELESS...

To read this piece, and more such stories in India's most exciting and exacting magazine, plus get access to our 25-year archives goldmine, please subscribe.


More from Ajay Sukumaran


Latest Magazine

December 07, 2020
content

other articles from the issue

articles from the previous issue

Other magazine section